Today the OECD marks the end of a seven year experimental testing programme, investigating 11 commercially viable nanomaterials across 110 chemical tests. The results were co-ordinated across 11 countries with tests and data generated from government agencies, universities, research institutions and businesses. Over 780 studies on the specific properties of nanomaterials were undertaken.
The OECD’s Annual Meeting at Ministerial Level reinforced member governments’ support across a broad range of key OECD work.
Innovation and creativity have long been hallmarks of the Czech Republic. After all, this is the country that invented the term “robot”, when Czech writer, Karel Čapek, coined the word back in 1921.
Governments would benefit from agreeing common principles for developing and communicating scientific advice, both in crisis situations and for long-term policymaking, according to a new OECD report.
This project has reviewed how current measurement frameworks capture the broad range of innovation activities in firms, and in particular how design activities are reflected. It highlights which concepts, definitions and measurement approaches can be used to produce policy-relevant indicators on the role of design in innovation.
This survey aims to collect information on the activities of scientific authors, from the underpinning research to its ultimate outcomes, covering the review, publication and dissemination processes.
OECD major events and activities relating to biotechnologies: latest developments are updated biannually in this Newsletter.
As in previous years, the goal of the 2014 IPSDM conference is to present the latest empirical evidence based on IP statistics and to discuss these findings with decision-makers from both the private and public sectors. The conference also aims to share cutting-edge knowledge on topics relevant to policy-makers, academics, companies and practitioners.
Squeezed R&D budgets in the EU, Japan and US are reducing the weight of advanced economies in science and technology research, patent applications and scientific publications and leaving China on track to be the world’s top R&D spender by around 2019, according to a new OECD report.
Statistics on biotechnology firms, biotechnology R&D (including public sector expenditures), biotech applications and patents.